Covid-19 in Brazil in 2020: Impact on Deaths from Cancer and Cardiovascular Diseases

Overview

Journal Rev Saude Publica

Specialty Public Health

Date 2022 Apr 27

PMID 35476100

Authors

Beatriz Cordeiro Jardim

Arn Migowski

Flavia de Miranda Correa

Gulnar Azevedo E Silva

Affiliations

Soon will be listed here.

Abstract

Objective: To analyze the impact of the covid-19 pandemic on mortality from cancer and cardiovascular diseases (CVD) as underlying cause and comorbidity in Brazil and Brazilian regions in 2020.

Methods: We used the 2019 and 2020 databases of the Mortality Information System (SIM) to analyze deaths occurring between March and December of each year that had cancer or CVD as the underlying cause or comorbidity. Deaths from covid-19 in 2020 were also analyzed. To estimate the Standardized Mortality Ratio (SMR) and the excess of deaths, 2019 data were considered as standard.

Results: Between March and December 2020, there were 181,377 deaths from cancer and 291,375 deaths from cardiovascular diseases in Brazil, indicating reduction rates of 9.7% and 8.8%, respectively, compared to the same period of the previous year. The pattern was maintained in the five Brazilian regions, with lower variation for cancer (-8.4% in the South to -10.9% in the Midwest). For CVD, the variation was greater, from -2.2% in the North to -10.5 in the Southeast and South. In the same period of 2020, these diseases were classified as comorbidities in 18,133 deaths from cancer and 188,204 deaths from cardiovascular diseases, indicating a proportional excess compared to data from 2019, of 82.1% and 77.9%, respectively. This excess was most significant in the Northern Region, with a ratio of 2.5 between observed and expected deaths for the two conditions studied.

Conclusions: Excess deaths from cancer and CVD as comorbidities in 2020 may indicate that covid-19 had an important impact among patients with these conditions.

Citing Articles

Fatality from COVID-19 does not affect palliative care duration among patients with advanced cancer: a retrospective cohort study.

Jomar R, Marques J, De Oliveira L, Mendes G, Cunha D, Guimaraes R Einstein (Sao Paulo). 2024; 22:eAO0536.

PMID: 39356939 PMC: 11461002. DOI: 10.31744/einstein_journal/2024AO0536.

Impact of the COVID-19 pandemic on cancer mortality in Brazil.

Cunha A, Antunes J BMC Cancer. 2024; 24(1):1125.

PMID: 39256699 PMC: 11384704. DOI: 10.1186/s12885-024-12761-1.

Unrecognised COVID-19 deaths in central Europe: The importance of cause-of-death certification for the COVID-19 burden assessment.

Fihel A, Janicka A, Buschner A, Ustinaviciene R, Trakiene A PLoS One. 2024; 19(7):e0307194.

PMID: 39012883 PMC: 11251637. DOI: 10.1371/journal.pone.0307194.

Excess mortality in adults from Sao Paulo during the COVID-19 pandemic in 2020: analyses of all-cause and noncommunicable diseases mortality.

Resende B, Dias R, Ferrari G, Rezende L Sci Rep. 2023; 13(1):23006.

PMID: 38155297 PMC: 10754941. DOI: 10.1038/s41598-023-50388-7.

Judicialization and cancer: quality of life of patients and caregivers in the COVID-19 pandemic.

Salha L, de Menezes J, Dias D, Brasil V, Ferreira P, de Santana Filho J Health Qual Life Outcomes. 2023; 21(1):87.

PMID: 37568236 PMC: 10422785. DOI: 10.1186/s12955-023-02173-3.

References

Azevedo E Silva G, Jardim B, Lotufo P . [Age-adjusted COVID-19 mortality in state capitals in different regions of Brazil]. Cad Saude Publica. 2021; 37(6):e00039221. DOI: 10.1590/0102-311X00039221. View

Fernandes G, Nassar Junior A, Azevedo E Silva G, Feriani D, Silva I, Caruso P . Excess mortality by specific causes of deaths in the city of São Paulo, Brazil, during the COVID-19 pandemic. PLoS One. 2021; 16(6):e0252238. PMC: 8184000. DOI: 10.1371/journal.pone.0252238. View

Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M . Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2014; 136(5):E359-86. DOI: 10.1002/ijc.29210. View

de Andrade C, de Aguiar Pereira C, Martins M, Lima S, Portela M . COVID-19 hospitalizations in Brazil's Unified Health System (SUS). PLoS One. 2020; 15(12):e0243126. PMC: 7728222. DOI: 10.1371/journal.pone.0243126. View

Fujino T, Nomoto H, Kutsuna S, Ujiie M, Suzuki T, Sato R . Novel SARS-CoV-2 Variant in Travelers from Brazil to Japan. Emerg Infect Dis. 2021; 27(4). PMC: 8007308. DOI: 10.3201/eid2704.210138. View

Dantas M, Bezerra de Souza D, De Souza A, Aiquoc K, de Souza T, Barbosa I . Factors associated with poor access to health services in Brazil. Rev Bras Epidemiol. 2020; 24:e210004. DOI: 10.1590/1980-549720210004. View

Riera R, Maria Bagattini A, Pacheco R, Pachito D, Roitberg F, Ilbawi A . Delays and Disruptions in Cancer Health Care Due to COVID-19 Pandemic: Systematic Review. JCO Glob Oncol. 2021; 7:311-323. PMC: 8081532. DOI: 10.1200/GO.20.00639. View

Malta D, Gomes C, Barros M, Lima M, Almeida W, Sa A . Noncommunicable diseases and changes in lifestyles during the COVID-19 pandemic in Brazil. Rev Bras Epidemiol. 2021; 24:e210009. DOI: 10.1590/1980-549720210009. View

Soares S, de Camargo Cancela M, Migowski A, Bezerra de Souza D . Digital rectal examination and its associated factors in the early detection of prostate cancer: a cross-sectional population-based study. BMC Public Health. 2019; 19(1):1573. PMC: 6881979. DOI: 10.1186/s12889-019-7946-z. View

10.

Baum A, Schwartz M . Admissions to Veterans Affairs Hospitals for Emergency Conditions During the COVID-19 Pandemic. JAMA. 2020; 324(1):96-99. PMC: 7275263. DOI: 10.1001/jama.2020.9972. View

11.

Marmot M, Allen J . COVID-19: exposing and amplifying inequalities. J Epidemiol Community Health. 2020; 74(9):681-682. PMC: 7577092. DOI: 10.1136/jech-2020-214720. View

12.

Izcovich A, Ragusa M, Tortosa F, Marzio M, Agnoletti C, Bengolea A . Prognostic factors for severity and mortality in patients infected with COVID-19: A systematic review. PLoS One. 2020; 15(11):e0241955. PMC: 7671522. DOI: 10.1371/journal.pone.0241955. View

13.

Ranzani O, Bastos L, Gelli J, Marchesi J, Baiao F, Hamacher S . Characterisation of the first 250,000 hospital admissions for COVID-19 in Brazil: a retrospective analysis of nationwide data. Lancet Respir Med. 2021; 9(4):407-418. PMC: 7834889. DOI: 10.1016/S2213-2600(20)30560-9. View

14.

. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020; 396(10258):1204-1222. PMC: 7567026. DOI: 10.1016/S0140-6736(20)30925-9. View

15.

Li L, Hang D, Dong H, Yuan-Yuan C, Bo-Heng L, Ze-Lin Y . Temporal dynamic in the impact of COVID- 19 outbreak on cause-specific mortality in Guangzhou, China. BMC Public Health. 2021; 21(1):883. PMC: 8105693. DOI: 10.1186/s12889-021-10771-3. View

16.

Degeling K, Baxter N, Emery J, Jenkins M, Franchini F, Gibbs P . An inverse stage-shift model to estimate the excess mortality and health economic impact of delayed access to cancer services due to the COVID-19 pandemic. Asia Pac J Clin Oncol. 2021; 17(4):359-367. PMC: 8014813. DOI: 10.1111/ajco.13505. View

17.

Breslow N, Day N . Statistical methods in cancer research. Volume II--The design and analysis of cohort studies. IARC Sci Publ. 1987; (82):1-406. View

18.

Blay J, Boucher S, Le Vu B, Cropet C, Chabaud S, Perol D . Delayed care for patients with newly diagnosed cancer due to COVID-19 and estimated impact on cancer mortality in France. ESMO Open. 2021; 6(3):100134. PMC: 8134718. DOI: 10.1016/j.esmoop.2021.100134. View

19.

Villain P, Carvalho A, Lucas E, Mosquera I, Zhang L, Muwonge R . Cross-sectional survey of the impact of the COVID-19 pandemic on cancer screening programs in selected low- and middle-income countries: Study from the IARC COVID-19 impact study group. Int J Cancer. 2021; 149(1):97-107. PMC: 8014228. DOI: 10.1002/ijc.33500. View

20.

Moynihan R, Johansson M, Maybee A, Lang E, Legare F . Covid-19: an opportunity to reduce unnecessary healthcare. BMJ. 2020; 370:m2752. DOI: 10.1136/bmj.m2752. View